(*) USA Approval Date: 2020. 12.17
(*) USA Approval Date: 2022. 07.27>
>BAFF MAb IV SC Use
BAFF: B-cell Activating Factor
Company
Generic Name: BelimuMAb
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2021. 12.28
Product Web-Site